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The reliability of a mechanized procedure for the determination of the glutamate dehydrogenase activity in human sera was investigated
with an Eppendorf analyzer 5011. In spite of a 1:3.5 ratio of sample to assay volume, carry-over effects can be neglected between sera
containing less than 60 U/l. For routine purposes it is suggested that 0.3 U/l be subtracted from each activity found in human sera and
that individual blank values are not measured.
Die Zuverlässigkeit einer mechanisierten Bestimmung der Glutamatdehydrogenase-Aktivität in menschlichem Serum wurde mit einem
Eppendorf-Automaten 5011 untersucht. Obwohl das Verhältnis von Probe- zu Ansatzvolumen 1:3,5 beträgt, können Verschleppüngs-
effekte zwischen Seren, die weniger als 60 U/l enthalten, vernachlässigt werden. Für Routineuntersuchungen wird vorgeschlagen, auf die
Bestimmung eines individuellen Probenleerwertes zu verzichten und 0,3 U/l als konstanten Betrag von der im menschlichen Serum ge-
fundenen Aktivität abzuziehen.
The activity of serum glutamate dehydrogenase (EC
1.4.1.3) has become a valid biochemical parameter for
the differential diagnosis of hepatic diseases (1—3).
For this purpose, the enzyme is determined routinely
on a large scale at our hospital. Therefore, a mechanized
procedure was evaluated for its reliability.
The activity of this enzyme was measured under "op-
timized" conditions according to SCHMIDT (4) and the
recommendations of the German Society for Clinical
Chemistry (5). This procedure includes the deter-
mination of a sample blank value. For purposes of
simplification we have investigated whether this blank
could be subtracted from the result as a fixed value.
Materials and Methods
Triethanolamine, NADH (Trisodium salt) and ADP were pur-
chased from C. F. Boehringer (D-68 Mannheim), control sera
from Merz and Dade (D-8 Munich), bovine albumin (purest) from
Behringwerke AG (D-355 Marburg) and all other chemicals p. a.
from E. Merck AG (D-61 Darmstadt).
Solutions
1. Triethanolamine buffer: 90 mmol/1
16.7 triethanolamine (Boehringer No. 15325), 1.675 g disodium-
ethylenedinitriloacetate (Merck No. '8418) + bidist. H2O to
1000 ml. The pH value should be 8.0, otherwise it must be ad-
justed. This solution can be stored at 4°C for some months.
2. 2-Oxoglutarate: 252 mmol/1
3.682 g 2-oxoglutarate (Merck No. 5194) + bidest. H2O to 100 ml.
This solution can be stored 4 weeks at 4°C.
3. Ammonium acetate: 900 mmol/1
6.937 g ammonium acetate (Merck No. 1116) -f bidist. H2O to
100 ml. This solution is stable for several months at 4°C
4. Nicotinamide-adenine-dinucleotide, reduced: 14.4 mmol/1
51.1 mg NADH (Boehringer No. 15142) -f bidist. H2O to 5 ml.
This solution can be stored 24 h at 4°C.
5. Adenosine diphosphate: 72 mmol/1
339.3 mg ADP (Boehringer No. 15691) + bidist. H2O to 10 ml
(Stable for 1 week at 4°C).
6. Reaction mixture:
Solution 1 40 ml
Solution 3 8 ml
Solution 4 1 ml
Solution 5 1 ml
The reaction mixture should be prepared immediately before
use; it can be stored for 6 h at 4°C.
Reaction mixture
Sample
500
200
Mixx and incubate 15 min at 25°C
Solution 2 20 \
Mix and record the reaction at 334 nm
The end concentrations of the assay are the same as recommended
by the German Society for Clinical Chemistry (5). Samples with
an activity of glutamate dehydrogenase (G1DH) above 30 U/l are
diluted 1 + 4 with Qualtrol (see Tab. 4).
Eppendorf micropipettes and an Eppendorf photometer (No.
1101 + 2705)1) with an analogue printer (Eppendorf No. 4414)
were used for the manual method. The mechanized procedure
was performed with an enzyme analyzer 5011 from Eppendorf
Gerätebau GmbH (D-2 Hamburg) following the instructions of
the manufacturer (Programming plug: HBDH/LDH; filter:
334 nm; transformation: 0—0.5; chart speed: 1 cm/min). The
glutamate dehydrogenase activity was calculated from the angle
which is formed between the direction of the moving chart paper
*) Automatic cuvette-positioning attachment.
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The sequence of samples introduced
into the Eppendorf enzyme automat
5011 for the determination of the
glutamate dehydrogenase activity.
The intersegment B can be repeated
as often as reqiured
xaxbxc 10 samples
Precision f rom-day- to -day
E22 control serum
d] bidist. water
-I—Segment -Segment C
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10 samples 10 samples
Dr i f t and end control
X3
Interaction control
ι ··
and a line drawn through the 7 points printed out by the analyzer:
tg α · 15 = U/l. The angle oc was measured with an Eppendorf
scale No. 2780. A table can be prepared containing the calculated
activity values (tgcx· 15—0.3) and the corresponding angle.
The sequence of samples introduced into the analyzer is shown
in Figure 1. Drift effects can be neglected and need not be monitored
because of the nature of the kinetic procedure. No drift of blank
or standard (6) was observed in batches containing up to 60
samples.
The detection limit was derived from the interbatch variation
(n = 15) of water samples Nos 5, 6, 9 and 10 (Fig. 1) as the
threefold standard deviation according to KAISER (7). The mean
was calculated from all 4 values.
The interaction from low to high concentrations (Q^ and from
high to low concentrations (Q2) was determined as recently
described (8) and expressed as the percent interaction coefficient
(Q = 100 · q; for the explantion. of q see Fig. 1). A sequence of
5 identical samples (Enzatrol, lot No. 233A) with a relatively low
activity of glutamate dehydrogenase (6 /1) was followed by
5 identical sera with a high activity (110 U/l) and finally by 5
samples with the low activity. Sera with a high glutamate dehy-
drogenase activity were prepared by mixing 5 ml .Enzatrol (Lot
No. ET 233A) with 50/til diluted glutamate dehydrogenase
suspension (2.5 ml Enzatrol + 10 μΐ glutamate dehydrogenase
No. 15140 from Boehringer-Mannheim). Monitrol Π solutions
containing various glutamate dehydrogenase activities were
obtained similarily.
The temperature at 25.0 ± 0.1°C was checked in the cuvettes
with a tastotherm instrument (Braun, D-6 Frankfurt) calibrated
against a thermometer.
For the determination of the precision 3 identical serum samples
(xa, Xb, Xc) are analyzed daily (Fig. 1): the precision within-series(GVs = I is calculated from the Xb — and xc valuess
 /
+
;s
J£(Xbl— Xci)2
i« l
2m ' ψ 2m
the precision from-day-to-day from the Xb — (or the xc) values
Results and Discussion
The procedure described above for the mechanized
determination of the glutamate dehydrogenase activity
in human serum samples is precise enough for clinical
diagnostic purposes (Tab. 1). Under these experimental
conditions an activity of up to 30 U/l can be measured
and up to 60 U/l if the recorder paper runs at 2 cm per
minute. Samples with higher activities must be diluted
1+4. The detection limit was 0.3 U/l (x = 0.26;
η = 4).
The activity of the glutamate dehydrogenase was
determined in serum samples from 97 patients by the
automated and by a manual procedure. The data
obtained with both methods show a good correlation
(Fig. 2).
Since.a relatively large sample volume is chosen, inter-
action effects have to be considered. The percent carry
over from high to low activities (Q2) was 1.5 ± 0.4
Tab. 1
The precision of the mechanized determination of the glutamate dehydrogenase (G1DH) activity. Monitrol II (3 ml) was mixed with 50 μ\ enzyme
suspension containing various glutamate dehydrogenase (G1DH) activities as described under methods
Precision within-series
(n) s CVs
Precision from-day-to-day
(n) s CVd
Monitrol II (-f- O1DH)
Enzatrol
Pooled human serum
3.1
6.5
11.4
14.1
26.7
32.4
5.2
4.4
7.5
7.8
(20)
(20)
(20)
(20)
(20)
(20)
(19)
(19)
(20)
(20)
0.30
0.30
0.40
0.39
0.51
0.49
0.17
0.38
0.26
0.48
9.7
4.6
3.5
2.8
• 1.9
1.5
3.3
8.6*
3.4
6.2*
5.2
5.2
(19)
(15)
0.43
0.44
8.3
8.4
* 100 μΐ sample + 500 μΐ reaction mixture; end concentration of the assay according to 1. c. (4, 5)
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Comparison of glutamate dehydrogenase activities in various serum
samples determined with automated and a manual procedure:
y = 0.9666x -f 0.0444; coefficient of correlation r = 0.9942 (n = 97)
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Fig. 3
The "interaction-safe range" (8) of the mechanized procedure for the
determination of the glutamate dehydrogenase activity. The con-
centrations forming this range are calculated according to 1. c. (8):
C,,i for the interaction from low to high concentrations and C8fi for
the interaction from high to low concentrations. The standard de^
viations were taken from Table 1. It is postulated that the error due
to carry over effects should be lower than the threefold (resp. twice)
value of the within-series precision (standard deviation)
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Fig. 4
The distribution of serum blank values in samples from 1626 patients.
Bidist. H2O was substituted for 2-oxoglutarate
determined on 10 different days, and could not be
detected from low to high activities (Qj). Using a
procedure recently developed (8), a so called "inter-
action-safe range" was calculated (Fig. 3) which dem-
onstrated that carry over effects can be neglected be-
tween samples containing less than 60 U/l. If a sample
must be diluted because of its high activity, the analysis
of the following sample must also be repeated.
In the test procedure proposed by SCHMIDT (4) an
individual blank value has to be determined in which
the substrate (2-oxoglutarate) is replaced by distilled
water. The distribution of 1626 blank values from
various patients shown in Figure 4 is not Gaussian.
The median is at 0.3 U/l. 93% of all values are not
higher than 0.5 and 97% not higher than 0.8.
For routine purposes we suggest that 0.3 U/l be sub-
tracted from each activity found in human sera and that
the determination of individual blank values be omitted.
However, it must be determined whether the discri-
mination at the borderline between normal and patho-
Tab. 2
Activity values (U/l) which are estimated falsely above the normal
range by the proposed procedure among 1616 unselected human sera
Patient
1
2
3
4
A
uncorrected
activity
4.0
4.0
3.5
3.7
B
as A, minus
0.3
3.7
. 3.7
3.2
3.4
C
as A, minus
individual
blank value
1.9
2.9
1.9
2.1
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Tab. 3
The influence of the sample volume on the glutamate dehydrogenase activity of various human sera. The volume of the reaction mixture (500 μ\)
and the end concentrations of the assay (according to 1. c. 5) were kept constant. A — assay value, Β = sample blank value (bidist. H8O was
substituted for 2-oxoglutarate), C = A—B. All figures are mean values (U/l) from 2 determinations
Sample
volume
No.
1
2
3
4
5
6
7
8
9
X
5
A
8.4 J
4.1
18.3
4.1 (
7.6
45.8
26.9
23.1
29.1
18.6
0//1
Β
2.5
.3
.0
).8
.3
.6
.3
.3
.3
.3
C
5.9
2.8
17.3
3.3
7.3
44.2
25.3
21.8
27.8
17.3
A
7.2
4.5
16.2
3.0
5.3
39.7
23.7
19.8
27.3
16.3
100 μ\
Β
0.9
0.7
0.9
0.5
0.9
1.4
0.9
0.9
0.9
0.9
C
6.3
3.8
15.3
2.5
4.4
38.3
22.8
18.9
26.4
15.4
A
6.1
3.4
12.2
2.6
4.0
29.5
18.2
16.1
21.9
12.7
200. μΐ
Β
0.8
0.8
0.3
0.5
0.3
0.8
0.4
0.5
0.8
0.6
C
5.3
2.6
11.9
2.1
3.7
28.7
17.8
15.6
21.1
12.1
A
6.7
3.4
13.3
1.9
3.6
23.4
18.0
15.4
21.7
11.9
300 μΐ
Β
0.2
0.2
0.3
0.2
0.2
0.4
0.3
0.2
0.5
0.3
C
6.5
3.2
13.0
1.7
3.4
23.0
17.7
15.2
21.2
11.6'
logical is not altered by the procedure just suggested.
This borderline is at 3 U/l according to SCHMIDT (4).
In 4 different sera out of 1626 the activity of glutamate
dehydrogenase, calculated by subtracting 0.3, was
above 3 U/l, whereas the results were below 3 U/l
when the correct individual blank values were used
(Tab. 2). Thus, the estimated activity of glutamate
dehydrogenase was falsely above the normal range in
0.25% of all human sera checked during this investiga-
tion. In these cases, however, the error was too low to
seriously mislead the physician. For scientific studies the
individual blank values should further be considered.
Since a large serum volume is used for the glutamate
dehydrogenase assay, the influence of sample volume
on the enzyme activity was investigated. It was found
with various sera that the glutamate dehydrogenase
activity declines with increasing the sample volume
(Tab. 3). This indicated that the proposed assay con-
ditions are not optimal for serum samples. SCHMIDT (4)
uses a 1:3.5 ratio between the volumes of the sample and
the reaction mixture. If this ratio is changed to 1:6 and
the end concentrations of the assay kept identical
according to 1. c. (5) the variation within series
batch increased significantly (Tab. 1). Because of this
result we suggest that the recommendation of SCHMIDT
(4) be followed. This appears to be a reasonable com-
promise for routine analytical purposes. The sample
blank value was also lowered if the serum volume was
increased (Tab. 3). The significance of this effect, which
could be caused by an inhibitor of the side reaction
present in human serum, requires further investiga-
tion.
Further experiments were performed to investigate
whether sera diluted with various solutions have
higher activities than undiluted samples. Serum samples
Tab. 4
The activity of the glutamate dehydrogenase in undiluted (A) and
serum sample diluted 1 + 2 with 0.9% NaCl (B), Qualtrol (C) and
albumine solution (70 g/1, D). All values (U/l) are means from 2
determinations
Patient
No.
1
2
3
4
5
6
7
8
9
10
A
26.8
26.8
30.0
16.4
15.5
25.7
22.8
8.0
24.7
13.5
B
29.4
28.2
34.2
17.4
13.8
24.0
27.3
11.1
24.0
13.8
C
28.2
26.1
31.8
17.4
12.0
21.9
23.4
8.7
23.1
11.2
D
31.8
28.2
35.7
19.2
16.5
27.3
30.6
9.6
27.8
•14.7
21.0 22.4 20.4 24.1
Tab. 5
The stability of the glutamate dehydrogenase activity in Enzatrol (Lot. No. ET 233 A) and human sera if stored at room temperature (A) and
at 4°C (B)
Time of
storage
Enzatrol*
Pat. 1
Pat. 2
Pat. 3
Pat. 4
Pat. 5
Pat, 6
•A
B
B
B
A
B
A
B
A
B
A
B
2h
5.6 ±0.2
5.8 ±0.2
7.2
ΙΪ.4
19.9
19.9
7.0
7.3
30.8
30.8
12.6
13.5
5h
5.2 ±0.3
5.5 ±0.3
7.2
11.8
19.2
19.9
7.0
7.3
—
—
—
—
24 h
4.6 ±0.4
5.2 ±0.3
7.2
12.9
19.2
19.9
6.7
7.0
28.2
29.5
12.2
12.7
48 h
4.2 ±0.4
4.8 ±0.2
7.3
—19.1
19.8
6.4
6.8
28.2
29.5
11.9
12.5
5 days
4.0**
4.6**
7.2
12.5
19.0
19.8
6.0
6.5
28.2
29.4
10.9
11.7
10 days
3.4**
4.1**
—
—
—
—
—
—17.0
23.7
6.7
9.8
* mean values from 7 (with standard deviation) and ** from 2 experiments
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from 10 different patients were diluted 1+2 with Serum should be stored no longer than 5 days at 4°C
0.9% NaCl, Qualtrol and albumin solution. The before the glutamate dehydrogenase activity is measured
glutamate dehydrogenase activity was determined in (Tab. 5). At the present time, Enzatrol is the only
these preparations and in undiluted samples. The commercial available serum which is suitable for the
results compared in Table 4 indicate that Qualtrol is quality control of the glutamate dehydrogenase deter-
suitable for the dilution of serum samples with gluta* mination. However, the activity of this enzyme declines
mate dehydrogenase activities above 30 U/l. Both constantly, 'especially during the first hours (Tab. 5).
Qualtrol and .the albumin solution contained no de- Therefore, we use Enzatrol for the control of precision
tectable activity of glutamate dehydrogenase. 24 h after its reconstitution.
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